Source:http://linkedlifedata.com/resource/pubmed/id/14656272
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:dateCreated |
2003-12-5
|
| pubmed:abstractText |
Mature results from GOG158 have clearly established carboplatin and paclitaxel as an effective and well-tolerated standard regimen, providing a basis for the reference arm in GOG0182-ICON5, an ongoing multiarmed phase III trial of the Gynecologic Cancer InterGroup (GCIG) evaluating the incorporation of newer cytotoxic agents. Results from GOG158 will be reviewed, including an analysis of second-look surgical outcomes, followed by an update on the current status of GOG0182-ICON5.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1048-891X
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
13 Suppl 2
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
149-55
|
| pubmed:dateRevised |
2007-11-15
|
| pubmed:meshHeading |
pubmed-meshheading:14656272-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:14656272-Carboplatin,
pubmed-meshheading:14656272-Cisplatin,
pubmed-meshheading:14656272-Clinical Trials, Phase III as Topic,
pubmed-meshheading:14656272-Female,
pubmed-meshheading:14656272-Humans,
pubmed-meshheading:14656272-Neoplasm Metastasis,
pubmed-meshheading:14656272-Neoplasm Staging,
pubmed-meshheading:14656272-Ovarian Neoplasms,
pubmed-meshheading:14656272-Paclitaxel,
pubmed-meshheading:14656272-Second-Look Surgery,
pubmed-meshheading:14656272-Survival Analysis
|
| pubmed:articleTitle |
Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel versus cisplatin and paclitaxel (GOG158) and an update on GOG0182-ICON5.
|
| pubmed:affiliation |
Division of Medical Science, Fox Chase Cancer Center, Philadelphia, PA 19111, USA. ma_bookman@fccc.edu
|
| pubmed:publicationType |
Journal Article
|